Profound Medical Corp. (TSX:PRN)
Canada · Delayed Price · Currency is CAD 9.27
-0.05 (-0.54%)
Jun 12, 2026, 4:00 PM EST
Profound Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18.81 | 16.1 | 10.68 | 7.2 | 6.68 | 6.87 | |
Revenue Growth (YoY) | 65.16% | 50.73% | 48.35% | 7.75% | -2.79% | -5.90% |
Cost of Revenue | 5.44 | 4.71 | 3.64 | 2.89 | 3.66 | 3.92 |
Gross Profit | 13.37 | 11.39 | 7.04 | 4.31 | 3.02 | 2.95 |
Selling, General & Admin | 30.43 | 32.05 | 23.13 | 18.54 | 17.93 | 17.97 |
Research & Development | 21.05 | 20.6 | 16.97 | 14.42 | 14.69 | 15.28 |
Other Operating Expenses | - | - | - | - | 2.52 | - |
Total Operating Expenses | 51.48 | 52.65 | 40.1 | 32.96 | 35.15 | 33.24 |
Operating Income | -38.11 | -41.25 | -33.06 | -28.65 | -32.13 | -30.29 |
Total Non-Operating Income (Expense) | -0.56 | -1.06 | 5.24 | 0.2 | 3.74 | -0.3 |
Pretax Income | -38.66 | -42.32 | -27.82 | -28.45 | -28.38 | -30.59 |
Provision for Income Taxes | 0.24 | 0.25 | -0 | -0.13 | - | 0.11 |
Net Income | -38.9 | -42.57 | -27.82 | -28.32 | -28.67 | -30.7 |
Net Income to Common | -38.9 | -42.57 | -27.82 | -28.32 | -28.67 | -30.7 |
Shares Outstanding (Basic) | 32 | 30 | 25 | 21 | 21 | 20 |
Shares Outstanding (Diluted) | 32 | 30 | 25 | 21 | 21 | 20 |
Shares Change (YoY) | 21.37% | 22.08% | 16.91% | 1.69% | 1.79% | 18.33% |
EPS (Basic) | 1.24 | 1.41 | 1.12 | 1.34 | 1.38 | 1.50 |
EPS (Diluted) | 1.24 | 1.41 | 1.12 | 1.34 | 1.38 | 1.50 |
EPS Growth | 1.64% | 25.89% | -16.42% | -2.90% | -8.00% | 20.00% |
Free Cash Flow | -38.51 | -38.38 | -23.45 | -22.61 | -25.8 | -22.39 |
Free Cash Flow Per Share | -1.21 | -1.27 | -0.95 | -1.07 | -1.24 | -1.09 |
Gross Margin | 71.07% | 70.77% | 65.89% | 59.90% | 45.22% | 42.95% |
Operating Margin | -202.56% | -256.27% | -309.57% | -397.99% | -480.86% | -440.73% |
Profit Margin | -206.76% | -264.44% | -260.45% | -393.43% | -429.11% | -446.66% |
FCF Margin | -204.67% | -238.43% | -219.60% | -314.06% | -386.17% | -325.80% |
EBITDA | -37.61 | -40.69 | -32.13 | -27.72 | -30.52 | -28.41 |
EBITDA Margin | -199.91% | -252.79% | -300.81% | -385.08% | -456.85% | -413.39% |
EBIT | -38.11 | -41.25 | -33.06 | -28.65 | -32.13 | -30.29 |
EBIT Margin | -202.56% | -256.27% | -309.57% | -397.99% | -480.86% | -440.73% |
Effective Tax Rate | -0.61% | -0.60% | 0.01% | 0.45% | 0.00% | -0.34% |